B lymphocyte and macrophages may contribute to SLE pathogenesis through cytokine production after TLR stimulation. Emerging evidences suggested that defects of sphingolipid metabolism were responsible for SLE pathogenesis. However, it is not clear whether these defects exist in B cells and macrophages under SLE condition and whether TLR signalling pathway was related to the dysfunction of sphingolipid metabolism in SLE. Here, we demonstrated that the enzymes involved in the sphingolipid metabolism expressed abnormally in B cells from SLE patients and lupus-prone mice. Moreover, we found that TLR signalling induced the abnormal expression of sphingomyelin phosphodiesterase 3 (SMPD3), sphingosine-1-phosphate phosphatase 2 (SGPP2), ceramide kinase (CERK) and UDP glycosyltransferase 8 (UGT8), which were involved in sphingolipid metabolism. TLR signalling also induced the transportation of SMPD3 from Golgi apparatus. Furthermore, the dysfunction of SMPD3 enhanced TLR-induced inflammatory response of B cells and macrophages in turn. Thus, these findings provide an innovative direction and a new target for research and treatment of SLE.
Introduction
Systemic lupus erythematosus (SLE) is a complex and chronic autoimmune disease, and the exact mechanisms are still confusing [1] . Activation of Toll-like receptors (TLRs) is one mechanism which is responsible for the loss of tolerance and the development of a chronic state of inflammation in SLE [2, 3] . B cell was constitutive expression of TLRs to sense endogenous molecules derived from injured or dying tissue as well as exogenous stimuli like products of bacteria and virus [4] . What's more, TLRstimulated B cell activation may contribute to SLE pathogenesis through antigen presentation [5, 6] and cytokine production [7, 8] except directly autoantibody production. All these indicate that B cell is an effective target for research and treatment of SLE [9, 10] .
Advances in biochemistry and molecular biology have suggested that sphingolipid metabolites play pivotal roles in the regulation of several fundamental biological process [11] . Just as its enigmatic properties named after the Sphinx, its diverse functions are expected to be an effective target for research and treatment of diseases. It has been confirmed that sphingolipid metabolism contributed to the pathological mechanism of cancer [11] , type 2 diabetes mellitus [12] and inflammation diseases [13, 14] . Specifically, ceramide, the precursor for a number of complex sphingolipids [15] , was reported to be major contributor to tissue dysfunction underlying metabolic pathologies [16] . Sphingosine-1-phosphate (S1P) and ceramide-1-phosphate (C1P) are the other two famous bioactive sphingolipids that are responsible for the excessive inflammation response [17] [18] [19] [20] . What's more, the enzymes involved in the sphingolipid metabolism to generate bioactive lipids are equally important to cell response and diseases [21] [22] [23] [24] [25] . So metabolites and enzymes involved in sphingolipid metabolism could be potential targets for research and treatment of diseases associated with lipid metabolism disorders.
Several studies have gradually reported the disorder of metabolism in SLE disease [26] [27] [28] [29] . All the results indicated that the metabolic dysfunction might contribute to the pathogenesis of SLE. Besides, emerging evidences showed the defects of both metabolite and gene involved in sphingolipid metabolism in PBMC from patients with SLE [23, 26] . Specifically, Georgia McDonald etc. demonstrated the defects of lipid metabolism in CD4 + T cell of SLE [27] . Their work hints the importance of lipid metabolism in immune cell to the pathogenesis of SLE. In addition to CD4 + T cell, B lymphocytes also take a pivotal part in the pathogenesis of SLE, as mentioned above. However, whether the defects of sphingolipid metabolism exist in B cell under SLE condition is not clear. What's more, what cause the dysfunction of sphingolipid metabolism in SLE is still under question.
To answer these questions, we reanalysed the B cell gene microarray of patients with SLE [30] focused on the sphingolipid metabolic pathway and the related signalling pathways. The microarray results demonstrated the defects of sphingolipid metabolism in B cell of patients with SLE. We then confirmed the defects of gene expression related to sphingolipid metabolism in splenic B cell and macrophages from SLE mice. These genes include sphingomyelin phosphodiesterase 3 (SMPD3), sphingosine-1-phosphate phosphatase 2 (SGPP2), ceramide kinase (CERK) and UDP glycosyltransferase 8 (UGT8). What's more, we found that TLR signalling pathway induced the differential expression of the related genes in both B cells and macrophages. And the dysfunction of sphingolipid metabolism enhanced the inflammation response of both B cells and macrophages in turn. We also demonstrated the transportation of SMPD3 from Golgi apparatus stimulated by TLR agonist. In conclusion, our results demonstrated the defects of sphingolipid metabolism in B cells from both SLE patients and lupus-prone mice. We also indicated that TLR signalling pathway contributed to the defects of sphingolipid metabolism and the dysfunction enhanced inflammation response of B cells and macrophages. Our results point out new direction for researching and treating autoimmune disease.
Materials and methods
Mice. Female C57BL/6J and B6.MRL-Faslpr/J lupus-prone mice were purchased from Model Animal Research Center of Nanjing University (Nanjing, China). All mice were bred and housed under specific pathogen-free conditions at the Animal Care Commission of Nanjing University. B6.MRL-Faslpr/J lupus-prone mice and the control mice were sacrificed at 20 weeks. Peritoneal macrophages, spleen, bone marrow (BM) and peripheral blood mononuclear cell (PBMC) were separated for the detection of gene expression.
Cell lines. Mouse macrophage cell line Raw 264.7 and B16 cell line were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 lg/ml) at 37°C in a humidified atmosphere with 5% CO 2 .
Chemicals and ligands. The following chemical was prepared in DMSO: GW4869 (Cayman Chemical, Ann Arbor, Michigan). The following chemicals were prepared in ddH2O: daunorubicin (DNR) (Sigma, St. Louis, MO, USA), CpG ODN 1826 (TCCATGACGTTCCT-GACGTT) (Invitrogen, Shanghai, China) and R848 (Enzo Life Science, Farmingdale, NY, USA). The following chemical was prepared in PBS: LPS (Sigma).
Analysis of microarray data. Whole blood (50 ml) from six healthy subjects (three males and three females) and six patients with active patients with SLE (three males and three females) were recruited for the microarray sample [30] . To evaluate the potential biological significance of the changes observed in the microarrays, network analysis of the differentially expressed genes was performed by Novel Bioinformatics Company (Shanghai, China). To determine the most significant biological functions and pathways of the differentially expressed genes, Kyoto Encyclopedia of Genes and Genomes (KEGG) were applied. And the significant KEGG pathways with P value <0.05 were selected. Based on the latest version of the KEGG database, the networks were built among those DEGs.
Generation of primary mouse B cell. Splenic cells were depleted of red blood cells by lysis in an ammonium chloride-containing buffer, and then, mouse B cells were separated by anti-CD45R (B220) antibody-coated microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the provided protocol. Mouse B cells were cultured in flat-bottom plates (Corning, Kennebunk, ME, USA) at a density of 1 9 10 6 /ml in RPMI 1640 (Gibco, Grand Island, NY, USA) supplemented with 10% FBS (Gibco) and antibiotics (penicillin 100 lg/ml, streptomycin 10 lg/ml; Invitrogen Life Sciences, Carlsbad, CA, USA) in a humidified atmosphere of 5% CO 2 at 37°C.
Construction of plasmids and transient transfection. Mouse SMPD3 cDNA was chemically synthesized. The product was cloned into pcDNA3.1s, resulting in SMPD3-containing pcDNA3.1 (Genechem, Shanghai, China). Then, SMPD3-containing pcDNA3.1 plasmid (0.5 lg/well) was transfected into RAW264.7 cells (24-well plate) using XtremeGENE HP DNA transfection reagent (Roche, Basel, Switzerland), according to the manufacturer's instructions. Empty vector was transfected as matched control. At 48 h after transfection, cells were harvested or used for subsequent experiments.
RNA extraction and quantitative real-time PCR. Total RNA was extracted using Trizol Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Real-time PCR assay was performed using the Applied Biosystems StepOne Sequence Detection System (Applied Biosystems, Foster City, CA, USA) using SYBR green dye (Invitrogen, USA) as per the manufacturer's instructions. All reactions were set up, in triplicate, in a 96-well optical reaction plate. The relative expression of the genes was calculated using 2-ΔΔCT formula using GAPDH as a normalizer. The values reported are the mean of at least three technical replicates. Primers used for realtime quantitative PCR analysis are shown in Table 1 .
Western blot. The cells were lysed with lysis buffer. Total lysates were resolved by SDS-PAGE and transferred to PVDF membranes (Millipore Corp., Bedford, MA, USA). Antibodies for phospho-JNK, JNK, phospho-ERK, ERK, phospho-P38, P38, phosphor-IjB, IjB and GAPDH for Western blot were ordered from Cell Signaling Technology (Danvers, MA, USA). SMPD3 (H-195) was purchased from Santa Cruz Biotechnology. Protein bands were visualized using ECL Plus Western blotting detection reagents (Millipore). GAPDH was used as an internal control. Each blot was a representative of three independent experiments. Band intensity was measured using ImageJ software (NIH, Bethesda, MD, USA), and the data were shown as fold value relative to the untreated control.
Enzyme-linked immunosorbent assay (ELISA). The supernatants from was collected and diluted for the measurement of IL-6 (BD Biosciences, San Diego, CA, USA), TNFa (Biolegend, San Diego, CA, USA), IL-1b (Biolegend) by ELISA according to the manufacturer's recommendations. A standard curve method was performed for each plate and used to calculate the absolute concentrations of the indicated cytokines.
Hoechst 33258 assay. Cells were seeded on sterile cover glasses placed in the 24-well plates. When they grew to approximately 80% confluence, cells were washed and serum deprived in the presence and absence of experimental compounds. At the end of the incubation period, cells were fixed, washed twice with PBS and stained with Hoechst 33258 staining solution (Beyotime, Shang Hai, China) for 5 min at room temperature and observed by FV10i confocal microscope (OLYMPUS, Tokyo, Japan). Fragmented or condensed nuclei were scored as apoptotic.
Flow cytometry assay. Flow cytometry was also performed to detect apoptosis by determining the relative amount of Annexin V + PI + cells, using an Annexin V-FITC kit and PI Apoptosis kit (eBiosciences, San Diego, CA, USA). Flow cytometry was performed on FACSCalibur (BD Biosciences), and data were analysed using FlowJo (Tree Star Inc., USA).
Immunofluorescence assays. The cells were seeded on poly-D-lysine-coated round coverslips (Citotest, Haimen, Jiangsu, China) and cultured in the 24-well plates overnight. After treatment by LPS and/or daunorubicin for indicated time, aspirate liquid then cover cells to a depth of 2-3 mm with 4% formaldehyde in PBS for 15 min and rinsed with PBS for three times. Then, cells were permeabilized with 100% methanol for 10 min at À20°C and blocked with 3% bovine serum albumin (BSA) in PBS for 60 min and incubated with primary antibodies anti-SMPD3 and anti-GM130 (Santa Cruz Biotechnology, Inc., Delaware Ave Santa Cruz, CA, USA) overnight at 4°C. After rinsing three times with PBS, incubated coverslips in fluorochrome-conjugated secondary antibody for 1-2 h at room temperature in dark and then stained the nucleus with DAPI (Bioword, Minnesota, USA). Finally, the coverslips were mounted onto the glass slides with neutral gum and observed by FV10i confocal microscope (OLYMPUS).
Measurement of N-SMase activity. SMPD3 activity was measured in macrophages via a sphingomyelinase assay kit (Biovision, Milpitas, CA, USA). The absorbance was measured at 570 nm. A standard curve of absorbance values of known amounts of choline standards was generated. One unit of sphingomyelinase activity was defined as the amount of enzyme that caused the formation of 1 lmol of choline per hour at 37°C. Sphingomyelinase activity in the samples (nmol/h/ml) was calculated from their corresponding absorbance values via the standard curve.
Statistical analyses. Statistical significance was determined with unpaired Student's t-tests, except as noted for analyses of microarray data, which were examined with Fisher's exact tests. P values <0.05 were considered statistically significant. Statistical calculations were performed with GraphPad Prism software (San Diego, CA, USA).
Results

Sphingolipid metabolism pathway dysfunction in B cells from patients with SLE and SLE mice
Our previous work has confirmed differential gene expression in B cells from patients with SLE compared to health controls [30] . A new evidence has suggested that the disorder of sphingolipid metabolism contributed to the pathogenesis of SLE [27] . To explore whether the defects of sphingolipid metabolism exist in B cells under SLE condition and what may cause the dysfunction of sphingolipid metabolism in SLE, we reanalysed the gene expression profiles of SLE B cells. Gene Sequence The significant KEGG pathways were selected based on the threshold of a P value <0.05. As the results ( Figure S1A ) showed, the metabolism pathway especially the sphingolipid metabolism pathway changed in the profiles. Considering the changed pathway listed in Figure S1A , we employed protein interaction network analysis based on the latest version of the KEGG database. In the network (Figure S1B ), we found that the different gene expression in autoimmune disease overlapped with the micro-organism infection pathway and Toll-like receptor signalling pathway. And the metabolism pathway also interacted with these changed pathways. Interestingly, we found genes expressed differentially in sphingolipid pathway in the network (Fig. 1A) . What's more, we found genes related to sphingolipid metabolism pathway from the microarray (CD19 + B cells from six active SLE patients and six healthy donors) expressed differentially (Fig. 1B) . It was reported that SMPD3 can catalyse sphingomyelin into ceramide and then CERK and UGT8 catalyse ceramide into ceramide-1-phosphate (C1P) and galactosylceramide, respectively. While SGPP2 can convert S1P into sphingosine (Fig. 1C) [31, 32] . The figure also shows the central position of SMPD3 and ceramide in the sphingolipid metabolism. To verify the difference showed in the genechip, we examined the mRNA expression levels in CD19 + B cells derived from spleens of mice. We did not measure GBA (Glucosidase, Beta, Acid) as the gene did not directly affect the SMPD3/ceramide pathway. Consistently, both SMPD3 and UGT8 were downregulated in splenic B cells from B6.MRL-Faslpr/J mice compared to splenic B cells from C57BL/6 mice (Fig. 1D) . On the contrary, the level of SGPP2 gene was higher in splenic B cells from lupus-prone mice than controls. Additionally, CERK, another gene related to sphingolipid metabolism pathway, was also decreased in lupus-prone mice.
Metabolites and genes involved in sphingolipid metabolism have been reported mostly in macrophages [18, 21, 22, 33] , so we separated the peritoneal macrophages from lupus-prone mice and the control mice to detect the expression of the genes. As Fig. 1E shows, SMPD3 and + B cells isolated from the peripheral blood of patients with SLE (n = 6) and healthy controls (n = 6) [30] . Hierarchical clustering analysis of differentially expressed genes (DEGs) (P < 0.05, FC > 2) associated with sphingolipid metabolism pathway was shown. Colour changes indicate the expression level relative to the average (log2 scale), and gene expression is shown in the heat map as upregulated (red colour), downregulated (green colour) and no change (black colour). (C) Schematic illustration of DEGs participated in sphingolipid biosynthesis. Particularly, SMPD3, UGT8 and SGPP2 that directly related to sphingolipid metabolism are indicated. (D-E) DEGs directly related to sphingolipid metabolism are validated by real-time PCR at mRNA level in B cells and peritoneal macrophages. All cells are isolated from lupus-prone mice (n = 10) and the control mice (n = 9). Each bar represents the mean AE SEM. *P value < 0.05, **P value < 0.05, ***P value < 0.001.
UGT8 were decreased, while CERK and SGPP2 showed no significant difference. We also detected the decreased levels of SMPD3 and UGT8 in splenic cells and peripheral blood mononuclear cells (PBMC) from lupus-prone mice ( Figure S2A, B) , while the expression of SGPP2 was increased in lupus-prone mice. The expression of CERK showed no significant difference in splenic cells and PBMCs. More importantly, we found decreased levels of SMPD3 and CERK in cells from bone marrow cells (Figure S2C) , and the expression of SGPP2 was still increased. But the level of UGT8 had no significant difference in bone marrow cells. So these results indicated that genes related to sphingolipid metabolism pathway expressed aberrantly in B cells and macrophages under SLE conditions. And this disorder also suggested that the sphingolipid metabolism pathway participated in the pathogenesis of SLE diseases.
TLR signalling induces the abnormal expression of genes related to sphingolipid metabolism Our pathway analysis results ( Figure S1A ) and the published articles [34, 35] confirmed the components of the microbes could regulate immune cell response through TLRs. B cell and macrophage express TLRs to sense and process antigens from microbes. To explore whether TLR signalling pathway could regulate sphingolipid metabolism, we separated splenic CD19 + B cells from C57BL/6 mice and then stimulated by LPS, R848 and CpG. CERK was downregulated, and SGPP2 was upregulated 3 h after stimulated by CpG (Fig. 2A) . What's more, LPS, R848 and CpG all decreased SMPD3, CERK and UGT8, meanwhile the level of SGPP2 was increased after TLR induction. We also detected the expression of SMPD3 at protein level by Western blot; all three ligands could effectively decrease SMPD3 protein expression (Fig. 2B) . SMPD1 has been reported to participate in the metabolism of sphingolipid [33] , and we found TLRs could also decrease the expression of SMPD1 ( Figure S3A ).
We then stimulated macrophage cell line Raw264.7 by LPS and R848. As Fig. 3D shows, both LPS and R848 could decrease the levels of SMPD3, CERK and UGT8, while IL-6 was increased at the same time (Fig. 2C) . Interestingly, SGPP2 was increased after the stimulation (Fig. 2D ). What's more, LPS and R848 could dramatically decrease the expression SMPD3 at protein level (Fig. 2E) . However, SMPD1 showed no significant difference after stimulated in Raw264.7 ( Figure S3B ). The results in both B cells and Raw264.7 indicated that TLRs might be the reason of sphingolipid metabolism disorder.
Deficiency of SMPD3 enhances the activation of TLR pathway induced by LPS Figure 1C shows the central position of SMPD3 and ceramide in the sphingolipid metabolism. To explore the direct effect of expression deficiency of SMPD3 in SLE, we used daunorubicin (DNR), an agonist of the SMPD3 and ceramide. As Fig. 3A shows, daunorubicin could effectively induce the expression of SMPD3 compared to controls. On the contrary, GW4869, an inhibitor of SMPD3, could decrease the level of SMPD3 to some extent. Then, Raw264.7 cell line was stimulated by LPS at different point in time after pretreated with daunorubicin for 1 h. As Fig. 3B shows, daunorubicin could effectively inhibit the activation of P38 stimulated by LPS. To determine whether this inhibition was dependent on SMPD3, we transfected Raw264.7 with SMPD3 plasmid before LPS stimulation (Fig. 3C) . Likewise, the overexpression of SMPD3 could effectively inhibit P38 activation induced by TLR signalling pathway (Fig. 3C ). So these results demonstrated that the expression of SMPD3 could prevent the excessive activation of P38 induced by TLRs. In turn, it also indicated that the deficiency of SMPD3 might exacerbate the activation of TLR signalling pathway in macrophages.
TLR-induced apoptosis of macrophages is not dependent on SMPD3
Thus, we observed the defective expression of SMPD3 in B cells and macrophages in lupus-prone mice, and this deficiency might exacerbate the activation of TLR signalling pathway. TLRs are responsible for the activation of B cells and macrophages, and the consequent cell apoptosis and inflammation response. And it has been reported that SMPD3 was involved in cellular process including apoptosis and inflammation signalling [25] . The microarray results also indicated this correlation ( Figure S1A, B) . So we detected whether SMPD3 regulated TLRs-induced apoptosis and/or inflammation response in macrophages.
The cell apoptosis was detected by annexin V/PI assay. Raw264.7 was pretreated with daunorubicin before stimulated by LPS and R848 for 12 h. The results from flow cytometry showed LPS, R848 and daunorubicin all could induce cell apoptosis as the increased percentage of annexin V/PI-positive cells, which was consistent with the reported articles (Fig. 4A) . What' more, daunorubicin enhanced the cell apoptosis induced by TLR signalling pathway (Fig. 4A) . The mean fluorescent intensity of PI also showed daunorubicin promoted TLR-induced apoptosis (Fig. 4B) . To confirm the results, the Hoechst 33258 staining was employed. As Fig. 4C shows, both LPS and daunorubicin could induce typical apoptotic morphological change of Raw264.7. Furthermore, pretreatment of daunorubicin and the subsequent LPS stimulation could induce significantly chromatin condensation and fragmentation. Because we have detected that LPS reduced the expression of SMPD3 (Fig. 2C, E) , and daunorubicin, the agonist of SMPD3, should have ............................................................................................................................................................... inhibited the effect induced by LPS if this apoptosis was dependent on SMPD3. To further examine the effect of SMPD3 on LPS-induced apoptosis,we transfected Raw264.7 with SMPD3 and the control plasmid pcDNA3.1 before LPS stimulated. And the results also showed that SMDP3 overexpression did not affect LPSinduced apoptosis (Fig. 4D) . Thus, the result demonstrated that SMPD3 did not regulate TLR-induced cell apoptosis in APC.
The expression of SMPD3 reduces TLR-induced inflammation response of macrophages
Then, we examined whether SMPD3 regulated TLRinduced inflammation response in macrophages. Likewise, Raw264.7 was pre-incubated with daunorubicin or GW4869 before LPS stimulation. As Fig. 5A shows, daunorubicin could effectively decrease the expression of IL-6 induced by LPS for 6 and 12 h, respectively. More Figure 2 Activation of TLRs in mouse B cells and macrophage cell lines induces the corresponding expression of DEGs related to sphingolipid metabolism. (A) Mouse B cells isolated from spleens were cultured with the treatment of LPS (100 ng/ml), R848 (500 ng/ml) or CpG (500 ng/ml), respectively. The mRNA levels of SMPD3, UGT8, SGPP2 and CERK were determined by real-time PCR after stimulation for 3 or 12 h. (B) The protein level of SMPD3 was determined by Western bolt after stimulation for 24 h, a representative of three independent experiments is given. Histograms showed the relative band intensity of Western blot from three independent experiments. (C-D) Macrophage cell line RAW264.7 was cultured with the treatment of LPS (100 ng/ml) or R848 (500 ng/ml), respectively. The mRNA levels of SMPD3, UGT8, CERK, SGPP2 and IL-6 were determined by realtime PCR after stimulation for 6 or 12 h. (E)The protein level of SMPD3 was determined by Western bolt after stimulation for 12 and 24 h; a representative of three independent experiments is given. Histograms showed the relative band intensity of Western blot from three independent experiments. Bars show the means AE SEMs of three independent experiments. *P value < 0.05, **P value < 0.05, ***P value < 0.001. Figure 3 The expression of SMPD3 regulates the activation of TLR signalling pathway. (A) RAW264.7 was cultured with the treatment of LPS (100 ng/ ml), DNR (0.2 lM) and GW4869 (2 lM), respectively. SMPD3 expression was determined at mRNA level. Bars show the means AE SEMs of three independent experiments. *P value < 0.05, **P value < 0.05, ***P value < 0.001. (B) RAW264.7 was pretreated with DNR for 1 h and then stimulated by LPS for 60, 30 and 15 min, respectively. The activation of TLR signalling pathway was determined by phosphorylation of ERK, IjB, P38 and JNK. A representative of three independent experiments is given. Histograms showed the relative band intensity of Western blot from three independent experiments. (C) RAW264.7 was transfected with pcDNA3.1-SMPD3 plasmid or pcDNA3.1 control plasmid for 48 h, and the expression of smpd3 was determined by Western blot. RAW264.7 was stimulated by LPS for 60, 30 and 15 min, respectively, after transfected with plasmid or pcDNA3.1 control plasmid for 48 h. The activation of TLR signalling pathway was determined by phosphorylation of P38. A representative of three independent experiments is given. Histograms showed the relative band intensity of Western blot from three independent experiments. Figure 4 The SMPD3 level has no effect on TLR-induced apoptosis of RAW264.7. (A-B) RAW264.7 was cultured with the treatment of LPS (100 ng/ ml), R848 (500 ng/ml), DNR (0.2 lM), LPS + DNR or R848 + DNR for 12 h, respectively. Percentage of Annexin V + PI + RAW264.7 was determined by flow cytometry. Representative FACS dot plots showed the percentage of Annexin V + PI + RAW264.7 cells. The MFI of PI on RAW264.7 cells was also analysed. Representative histogram of three independent experiments was given. (C) RAW264.7 was incubated with LPS (100 ng/ml), DNR (0.2 lM), LPS + DNR for 12 h, respectively. At the end of the incubation, the cells were washed, fixed and stained with Hoechst 33258. Cells with condensed chromatin and fragmentation were defined as apoptotic RAW264. ............................................................................................................................................................... interestingly, levels of TNF-a induced by LPS were also inhibited by daunorubicin (Fig. 5A) . To confirm the results we detected the secretion of IL-6 and TNF-a by ELISA assay. Pre-incubation with daunorubicin could reduce the secretion of IL-6 as well (Fig. 5B) . Although there is no significant difference, GW4869 could promote the expression of IL-6 to some extent. As for TNF-a, daunorubicin could decrease its secretion at 12 h. However, GW4869, an inhibitor of SMPD3, could effectively enhance its expression induced by LPS for 6 h. What's more, we examined the effect on the expression of IL-1b. daunorubicin inhibited its expression while GW4869 promoted IL-1b secretion (Fig. 5C) . Finally, we examined the effect on anti-inflammation cytokine. GW4869 could decrease IL-10 expression induced by LPS at 6 h, while daunorubicin promoted IL-10 expression induced by LPS after 12 h (Fig. 5D ). To verify whether the effect was dependent on SMPD3 directly, we transfected SMPD3 Figure 5 The expression of SMPD3 influences TLR-induced inflammation response in RAW264.7 and B cells. RAW264.7 was cultured with the stimulation of LPS (100 ng/ml) after pretreatment with DNR (0.2 lM) or GW4869 (2 lM) for 1 h. (A) The mRNA levels of IL-6 and TNF-a were determined by real-time PCR after stimulation for 6 or 12 h. (B)The protein levels of IL-6, TNF-a were determined by ELISA after stimulation for 6 or 12 h. (C)The mRNA level and protein level of IL-1b were examined by real-time PCR and ELISA, respectively. (D) The mRNA level of IL-10 was determined by real-time PCR after stimulation for 6 or 12 h. (E) The mRNA level of IL-1b, IL-6, TNF-a and IL-10 was detected in RAW264.7 after transfected with pcDNA3.1-SMPD3 plasmid or pcDNA3.1 control plasmid for 48 h. (F) Mouse splenic B cell was isolated and cultured with the stimulation of LPS (100 ng/ml) after pretreatment with DNR (0.2 lM) or GW4869 (2 lM) for 1 h. The mRNA level of IL-10 was determined by real-time PCR after stimulation for 12 or 24 h. Bars show the means AE SEMs of three independent experiments. *P value < 0.05, **P value < 0.05, ***P value < 0.001.
Scandinavian Journal of Immunology, 2017, 86, 377-388 384 TLR-Induced SMPD3 Dysfunction in B Cell from SLE plasmid into Raw264.7 cell line. Interestingly, the overexpression of SMPD3 effectively decreased the expression of IL-6, TNF-a and IL-1b (Fig. 5E ). And the expression of IL-10 was also upregulated to some extent. To confirm whether this effect was applicable to B cells, in which we found the defect of sphingolipid metabolism in SLE. We pretreated B cells with daunorubicin or GW4869 before LPS stimulation, and the results showed GW4869 could effectively reduce the expression of IL-10 while daunorubicin promoted its expression in B cells stimulated by LPS (Fig. 5E) . Collectively, the results in Raw264.7 and B cell demonstrated that the decrease of SMPD3 enhanced TLR-induced inflammation; thus, the deficiency of SMPD3 in SLE was responsible for the excessive inflammation response of B cells and macrophages.
TLR signalling promotes the transportation of SMPD3 from Golgi apparatus Hannun YA etc. have reviewed that the transport direction of SMPD3 was associated with its biological functions and its relevance to pathology [25] . It also implied that the transportation of SMPD3 from Golgi apparatus to plasma membrane might promote inflammation response. To clarify the excessive inflammatory response mediated by SMPD3 completely, we examined the location of SMPD3 by confocal microscopy. Raw264.7 was stimulated by LPS for 12 and 24 h, and the combination of SMPD3 with GM130 in Raw264.7 was reduced obviously (Fig. 6A) . This demonstrated that the location of SMPD3 at Golgi apparatus was decreased. We repeated the assay in B16 cell line. The colocalization of SMPD3 with GM130 also reduced ( Figure S4A ). The colocalization results demonstrated that the transportation of SMPD3 might also contributed to the excessive inflammation response.
Besides, the activation of neutral sphingomyelinase was also reported to participate in TLR signalling pathway [36, 37] . In particular, the lower neutral sphingomyelinase activities upregulated TNF-a production in macrophage [37] . Here, we found that the activities of neutral sphingomyelinase had no significant difference after stimulated by LPS for 6 and 12 h in RAW264.7 (Fig. 6B) . These results demonstrated that the decreased expression of SMPD3 was mainly responsible for the excessive inflammation response in a relative long period of time.
Collectively, our results demonstrated the disorder of sphingolipid metabolism of B cells and macrophages in SLE patients and lupus-prone mice. And we also inferred TLR signalling pathway induced the dysfunction of sphingolipid metabolism in B cells and macrophages. Particularly, TLR pathway contributed to the decrease of SMPD3 and the transportation of SMPD3 from Golgi apparatus. What's more, all these response enhanced TLRinduced inflammation in turn through p38 signalling pathway (Fig. 7) . In short, the study suggested sphingolipid metabolism took a part in the pathological mechanism of SLE by enhancing inflammation response in B cells and macrophages.
Discussion
A growing body of literature supports the idea that sphingolipid metabolism plays a major role in many facets of cell physiology and pathophysiology. And sphingolipid metabolic disorders attribute to the dysfunction of cell immune response. However, few study has addressed what caused the dysfunction of sphingolipid metabolism in SLE and the effects contributed to SLE pathology. Herein, we demonstrated TLR signalling pathway induced the disorder of sphingolipid metabolism in B cell, and sphingolipid metabolic dysfunction induced the excess inflammation ............................................................................................................................................................... response stimulated by TLR signalling pathway in turn. Thus, the paper not only confirmed the metabolic dysfunction in SLE but also suggested one of the causes and the consequences of this perturbation.
The article for the first time confirmed the differentially expressed genes related to sphingolipid metabolism including SMPD3, SGPP2, CERK and UGT8 in B cell of SLE. We found the abnormal expression of these genes in B cell gene microarray of patients with SLE and examined them in B cells and a variety of different organizations from lupus-prone mice. It has been reported that SMPD3 pathway regulated the survival and inflammation response of immune cells [14, 25] . It should be indicated that we also demonstrated the reduction of UGT8 in SLE B cell. This tentatively put forward the decrease of galactosyl ceramide (GalCer) in B cells of SLE. This is interesting because many references have confirmed that the addition of a-galactosyl ceramide (a-GalCer) could meliorate the disease symptoms of SLE [38] . Previous studies by our group have demonstrated that TLR induced the decrease of CD1d expression and weakened the interaction between B cells and iNKT cells [6] . Here, it should be demonstrated that the subdued interaction between B cells and iNKT cells could be partly attributed to the reduction of inherent GalCer, although the level and function of intracellular GalCer still needs further verification [39] [40] [41] . In a word, the results we showed once again confirmed the dysfunction of sphingolipid metabolism in SLE.
Actually, several studies have already addressed the disturbance of metabolism in patients with SLE recently [26] [27] [28] [29] . Specifically, both McDonald G [27] and Yin YM [29] indicated metabolism defects in CD4 + T cells from patients with SLE. All the works could be proofs of principle that metabolism can be targeted to reverse a complex spontaneous autoimmune disease. Besides, although glycosphingolipid (GSL) also belongs to lipids, GSL levels were markedly increased in CD4 + T cells from with SLE patients [27] . The work together with our results in B cells and macrophages hints the complexity of metabolism in SLE. So specific metabolite and its concrete function in certain cells and tissue still need further research in SLE.
Still, sphingolipids are emerging as major players in the aetiology and pathology of a number of diseases and we cannot put too much emphasis on the importance of sphingolipid metabolic studies [42, 43] . Our microarray from SLE showed the correlation between ceramide and insulin ( Fig. 1) . Interestingly, Holland WL etc. have suggested the inhibition of ceramide synthesis could ameliorate insulin resistance [12] . They also confirmed that dexamethasone induced the ceramide biosynthesis. It has already been confirmed that dexamethasone was beneficial to treat lupus [44] . Although whether the treatment effect is partly dependent on the ceramide biosynthesis is open to question, it hints again that ceramide might be a potential target for SLE treatment.
Finally, our study indicates the importance of microbes and TLR signalling pathway on the pathology of SLE (Fig. 1A) . TLR signalling pathway is responsible for the excessive inflammation in SLE [2, 3] . At the mean time, lipid metabolism and inflammation are closely linked and the crosstalk between these processes is fundamental to the pathogenesis of human diseases [13] . So it is plausible that sphingolipid metabolism could be a mediator of TLR signalling [24] and this process might enhance the inflammation response stimulated by TLR in SLE.
In summary, this study not only indicated the dysfunction of sphingolipid metabolism in SLE disease, but also for the first time suggested TLR signalling pathway induced the defects and this disturbance enhanced inflammation response in B cells and macrophages stimulated by TLR in turn. Importantly, the results confirmed Figure 7 Schematic illustration of TLRinduced SMPD3/ceramide pathway in the pathogenesis of SLE. TLR signalling pathway not only regulates the levels of metabolic enzymes but also influences the transportation and location of SMPD3, and all these actions enhance TLR-induced inflammation response through p38 signalling pathway in turn.
the key role of sphingolipid metabolism in SLE pathology. So these findings provide new target for the therapy of SLE and point out another direction for researching autoimmune disease.
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